2026-9-3 (Thu)

Business NVIDIA Corporation (NASDAQ: NVDA) is a data-center-scale AI infrastructure company designing GPUs and accelerated computing/networking platforms that power the generative-AI boom. The world's most valuable company, it derives the bulk of revenue from data-center AI chips such as Blackwell, software, and networking.

Today’s take NVDA closed Sep 3, 2026 at $228.45 (+$4.04, +1.80%), building on a prior-session gain of 3.2% to $224.41. The primary Sep 3 catalyst was NVIDIA's official confirmation, via CEO Jensen Huang's blog post Thursday, of its ~$12.93B acquisition of open-source AI platform Hugging Face — NVIDIA's second-largest deal ever, after ~$20B for Groq assets. Analysts (Rosenblatt, Raymond James) framed the deal as a strategic move up the AI software stack that broadens the moat beyond chips. The rally extended follow-through from Dell's Sept 2 blowout Q2 (record $60.9B AI-server orders, $95B backlog, AI-server revenue +100% to $16.4B, FY27 forecast raised to ~$192B), which analysts (D.A. Davidson, Wedbush) said validated NVIDIA's AI-demand thesis beyond hyperscalers. This follows NVDA's own Q2 FY27 (Aug 26): revenue $96.2B (+106% YoY) with data center ~$89B.

Business Space Exploration Technologies Corp. (SpaceX) is a vertically integrated aerospace manufacturer, orbital launch provider, and satellite-connectivity and AI-infrastructure company led by Elon Musk, dual-listed on Nasdaq Global Select and Nasdaq Texas under ticker SPCX (IPO June 12, 2026 at ~$135). Its segments span Falcon/Starship space launches, Starlink broadband (~12M subscribers), and data-center/AI cloud ('orbital compute') services.

Today’s take SpaceX rose 6.42% (+$9.03) to $149.74 on Sep 3, 2026, hitting a three-month intraday high of $152.30 on 120.5M shares. The primary, directly-timestamped catalyst was an analyst upgrade: on Sep 2 Oppenheimer's Timothy Horan lifted his price target to $280 from $250 (reiterating Buy/Outperform), arguing SpaceX can bring AI infrastructure online faster than peers and channeling ~50% of revenue from partners like Anthropic in a compute-constrained environment. This was amplified on Sep 3 by a dovish Fed macro read—Governor Christopher Waller signaled support for holding rates steady, knocking the 10-year Treasury yield ~5bp lower to ~4.74% and fueling a growth/tech rally (Nasdaq +1.4%). Adding event-positioning, SpaceX submitted an FCC application to operate Starlink terminals on Starship Flight Test 14 (mid-September window), while momentum continued to follow through on the strong Aug-4 Q2 print (revenue $7.81B, +91.9% YoY; AI revenue +247% to $2.56B).

Business Nu Holdings Ltd. (NYSE: NU) is the Cayman-incorporated parent of Nubank, a Sao Paulo-headquartered digital bank and one of Latin America's leading fintechs, with roughly 139 million customers across Brazil, Mexico and Colombia and early expansion into the United States via conditional OCC approval for Nubank NA.

Today’s take NU's September 3, 2026 gain of +1.82% to $15.68 was a continuation of a two-day post-catalyst re-rate rather than a fresh single-day fundamental print. On Sept 1-2 the stock surged ~6.5% to $15.40 after an analyst lift of fair value to $23.00, plus a fresh $1B share buyback, following record Q2 earnings (Aug 13) with net income of $1.1B - the first quarter ever above $1B - on $5.9B revenue (+39% YoY), 33% ROE, and 139M customers. Additional target raises supported the move: Needham to $19.00, UBS to $18.20, Citi and BTG Pactual also upgrading, with 9 Buy/4 Hold/1 Sell on Wall Street. The rally was amplified by a Brazil bank-sector advance driven by domestic and foreign equity inflows. On Sept 3 NU opened at $15.67, printed a high of $15.84 (a near-term recovery high) and closed at $15.68, up 1.82%. Broad institutional sentiment turned bullish as Wall Street viewed the stock ~undervalued vs fair-value estimates of $22-23, though credit quality (NPL ~4.8%) and Brazil cycle risk remain watch items.

Business Intel Corporation (NASDAQ: INTC) is the world's leading designer and manufacturer of x86 processors, AI accelerators and chip foundry services (Intel Foundry), serving PCs, servers, data centers and edge markets. The company is mid-way through a turnaround centered on its 18A/14A process roadmap and IDM 2.0 foundry strategy.

Today’s take Intel rose 1.80% to close at $91.67 on Sept 3, 2026, outperforming the S&P 500's +1.06% day. The move was driven by a blend of sector and company-specific catalysts. Broader markets ended a three-day losing streak as AI/tech rebounded sharply — NVIDIA +3.21%, Dell +15.8% after raising guidance, Micron +2.43%, and the Philadelphia Semi index firming — setting a positive backdrop. Company-specific drivers included a Nova Lake-S roadmap leak (via @wxnod, Sept 3) confirming Q4 2026 mass production and a Q1 2027 launch of Core Ultra 400 CPUs, plus lingering bullish read-through from CFO Zinsner's Deutsche Bank Conference remarks that 14A defect-density reduction was Intel's fastest since its 22nm/2012 node, with 0.9 PDK due in October and risk production in H2 2027. CEO Lip-Bu Tan's ~$10M share purchase at $95 (concurrent with the $20B offering) reinforced confidence, and Cboe data showed bullish call-skewed flow (put/call 0.39 vs. ~0.55 typical). Partially offsetting was Mizuho's price-target cut to $92 from $109 (Hold), which likely capped gains near the $92 resistance.

Business Nokia Oyj is a Finnish public limited-liability company and global leader in telecommunications and network infrastructure, positioning itself as 'connectivity for the AI era.' Core operating lines include Network Infrastructure (optical, IP routing, fixed/submarine), Mobile Networks (RAN/5G-6G), Cloud and Network Services, and the Nokia Technologies licensing arm. Its NYSE-traded ADRs are tracked here.

Today’s take NOK's 9/3 close at $9.77 (-0.71%) marked a fourth consecutive drop and continued de-rating from the ~$13.5 mid-June peak, leaving the ADR ~28% below recent highs and ~44% under the 52-week high of $17.45. No company-specific event hit on 9/3; the session was dominated by a weak European tape at one-month lows on Middle East tensions, firmer oil and rising sovereign yields, plus sustained sector-wide cooling of AI/telecom momentum names. The positive idiosyncratic catalyst — rejoining the EURO STOXX 50 (effective Sept 21, announced ~Sept 1) — was already known and fully faded; the post-announcement +1% after-hours pop did not carry through, and the ADR then slipped 2.1%, 0.9% and 0.7% over the next three sessions even as Helsinki shares rose ~2%. Fundamentals stay healthy (Q2 AI/cloud order intake €2.8B; Optical +20%), supporting JPMorgan's Overweight/$21, but positioning and momentum lean bearish near term.

Business Ondas Inc. (NASDAQ: ONDS), formerly Ondas Holdings, is a defense, security and critical-infrastructure technology company with two units: Ondas Networks (FullMAX software-defined radio) and Ondas Autonomous Systems (drones/counter-UAS). Through its Mistral Inc. acquisition (completed April 2026), it acts as a U.S. defense prime contractor on Army programs worth over $1 billion.

Today’s take ONDS closed Sept 3, 2026 at $7.63, +0.26%, after opening at $7.69, spiking to an intraday high of $7.95, then fading to near-flat — classic profit-taking after Sept 2's +8.10% tariff-driven surge to $7.61 (off a Sept 1 -8.03% drop). The dominant theme was the effective date (Thursday) of Trump's 100% tariff on imported drones and parts, a sector-wide catalyst per IBD/Stockstar. Short interest sat near ~40-44% of float (≈230M shares), keeping the name highly reactive, with the stock down ~22% YTD. The session saw momentum carry over early but fade amid risk-off behavior among elevated-short-interest drone names, with no company-specific news that day. Context: record Q2 revenue of $83.8M (+13x YoY) yet a net loss of $89.7M and a ~41% shorted float.

Business Hewlett Packard Enterprise Company (NYSE: HPE) is a global edge-to-cloud enterprise technology company headquartered in Houston, Texas. It provides servers, storage, networking, AI infrastructure and software/services built on Juniper and Aruba networking to enterprise, cloud and sovereign customers.

Today’s take HPE reported fiscal Q3 2026 (quarter ended July 31) after the Sept 2 close: record revenue rose ~34% YoY to $12.2B (vs ~$11.9-12.0B consensus), record non-GAAP EPS of $1.11 beat the ~$0.93 estimate, with record 40% gross margin, ~$2B operating profit and $958M FCF. Management raised FY26 revenue growth guidance to +34-37% and adjusted EPS to $3.75-$3.85 (from $3.35-$3.45), projecting FY27 revenue growth of 13-17%. Management also flagged memory/supply constraints as the main bottleneck and expanded its Oracle deal to deploy Juniper networking inside Oracle AI data centers (with an option for Oracle to buy ~$205M of HPE shares at a discount). Despite the beat-and-raise, shares initially dropped over 8% post-close to ~5-6% lower premarket on supply worries after a ~112-120% year-to-date run. On Sept 3 the stock gapped down sharply (open 47.60, intraday low 45.70, about -12%) before staging a massive intraday reversal to close at $54.44, up +5.04% on the day, +3.8% above prior close $51.83.

Business MARA Holdings, Inc. (NASDAQ: MARA) is a digital-asset technology and energy/digital-infrastructure company and historically one of the world's largest publicly traded Bitcoin miners. It secures the blockchain and supports the energy transition by converting clean, stranded, or underutilized energy into mining and grid-balancing compute, and holds a large corporate Bitcoin treasury. It has pivoted from a strict 'HODL'/'Twin-Turbo' mining-plus-buying model toward AI/HPC compute and power-allocation services; given its big Bitcoin balance sheet, the stock trades as a high-beta proxy for Bitcoin price.

Today’s take MARA surged 10.79% to $11.60 on Sep 3, 2026, riding a sector-wide crypto rally ignited when Bitcoin broke back above $80,000 to roughly $81,105 (up ~4.8%), its best level in about three months. The trigger was macro: Fed Governor Christopher Waller signaled he would support keeping rates unchanged if August inflation cools, slashing market bets on a September hike and lifting risk assets. High-beta miners and coin proxies jumped together on the day - Strategy +15%, Coinbase +10.6%, Circle +15.8%, Canaan +23.4%, Riot +11.4%, Bit Digital +15.8% - with U.S. Treasury bond-repurchase support and President Trump's crypto 'Clarity Act' push in the backdrop. Notably, Morgan Stanley initiated MARA at Underweight with an $8 target the same session, arguing unattractive mining economics and limited data-center-pivot upside, but the overwhelming Bitcoin bid overshadowed that bearish note. MARA remains a leveraged play on Bitcoin and interest-rate expectations rather than company-specific news.

Business Pacific Gas & Electric Corporation (NYSE: PCG) is an investor-owned utility holding company whose principal operating subsidiary, Pacific Gas and Electric Company, generates, procures, transmits and distributes electric power and natural gas across northern and central California, serving residential, commercial and industrial customers.

Today’s take On 2026-09-03, PCG rallied +4.73% to close at $13.96 (open $13.35; high $14.11; low $13.29; volume 65.6M) as a measured relief bounce off the prior days' volatility. On Aug 31, California's Assembly shelved SB 492, leaving wildfire liability reform unresolved and knocking the stock ~18%. On Sep 2, PG&E launched a Strategic Review Committee (board-authorized) to pursue investment-grade credit ratings, deferred ~$2B of 2027 capex to $11.4B, reaffirmed 2026 core EPS of $1.64–$1.66 and initiated 2027 guidance of $1.78–$1.82 (~9% growth). That same day the stock hit a 3-year intraday low near $12.59–$13.05 amid downgrades (Truist to Hold $17; Mizuho to $14). On Sep 3, the tape ground higher all day in a controlled stair-step (not a squeeze), supported by management reaffirming its financial plan and fresh analyst actions (UBS Buy, Goldman Buy maintained; BMO Hold $21; Mizuho Hold $14; Truist downgrade).

Business NIO Inc. (NYSE: NIO) is a Chinese premium smart electric-vehicle (EV) manufacturer designing, developing and selling electric SUVs and sedans under its own brand, along with battery-swap and autonomous-driving technologies.

Today’s take On 2026-09-03 NIO shares closed unchanged at $3.86 (+0.00%) after two steep post-earnings declines (Sept 1 -4.02% and Sept 2 -4.93%). The session was pure consolidation/stabilization after Q2 FY26 results (released Sept 1) triggered a wave of analyst actions: JPMorgan cut to Neutral (PT $7->_$4.50), Freedom Broker downgraded to Hold (PT $4), and, on the target session itself, Royal Bank of Canada downgraded NIO to Sector Perform. NIO fell to a fresh intraday 52-week low of $3.71 on Sept 3 before buyers recouped losses into the flat close, trading range 3.71-3.90. Stock is far below its $8.02 52-week high. Volume ~62.2-62.9M was heavy (~2x the ~33M 30-day average), placing NIO on NYSE's most-active list as the market digested downgrades, a fresh 52-week bottom, and short-term dip-buying rather than any constructive up-catalyst.

Business ChargePoint Holdings, Inc. (NYSE: CHPT) is a Delaware-incorporated EV charging infrastructure company headquartered in Campbell, California. It designs and sells networked electric-vehicle charging hardware and cloud-based subscription software/services across North America and Europe, operating over 342,000 active charging ports rather than owning its own charging network.

Today’s take ChargePoint surged 74.95% to close at $9.08 on Sept 3, 2026 after reporting fiscal Q2 FY2027 (quarter ended July 31, 2026) results after market close on Sept 2. Revenue hit $116.1M, up 17.7% YoY and beating ~$105.2M consensus. Adjusted EPS of -$0.35 beat the -$0.85 estimate. Adjusted EBITDA loss narrowed 78% to $4.75M (versus -$22.1M year prior), record 38% gross margin (35% normalized ex a ~$4.2M one-time tariff refund), essentially zero cash burn, and inventory fell to ~$179M. CDO Rick Wilmer said the move marked 'the beginning of the momentum,' citing the fourth straight quarter of YoY growth, early Express Solo DC platform shipments (co-developed with Eaton; 10-80% charge in ~11 min at 600+ kW), and AI-driven efficiencies. FQ3 FY2027 guidance of $105-115M revenue (midpoint ~$110M, ~4% YoY) modestly backed consensus. Management candidly flagged elevated North America home-charging sales that are not expected to recur, a one-time tariff refund, and ongoing tariff/trade uncertainty. This was a company-specific post-earnings surprise re-rating rather than a sector or macro event.

Business Antelope Enterprise Holdings Limited is a Nasdaq Capital Market-listed holding company. Through its 51%-owned subsidiary Kylin Cloud it operates a China livestreaming e-commerce business, while pursuing a digital-asset ('Genius Plan') Bitcoin treasury strategy and U.S. power generation for data centers/AI infrastructure.

Today’s take On Sept 3, 2026 AEHL surged +37.20% to close at $7.45 (open 8.05, high 8.30, low 6.55) on 21.38M shares, roughly 5.8x its ~3.7M 20-day average. The move was part of a broad crypto-concept rally triggered that day by SEC Chairman Paul Atkins' remarks urging Congress to pass the CLARITY Act (procedural vote set for Sept 15) and pursue a crypto regulatory framework. AEHL has re-positioned as a Bitcoin-treasury micro-cap: it launched its $100B-target 'Genius Plan' (Feb 2026), completed an initial $1M BTC purchase, and authorized a $95K BTC-funded buyback, making it a high-beta crypto play. Amplifying gains was an extreme thin-float structure: post a 1:16 reverse split (effective Aug 7/10) float is only ~973K shares with market cap ~$10.4M and financial distress (FY loss ~$13.5M, gross margin 0.36%). The stock had seesawed violently around an Aug 24 $18.99M dilutive private placement (15M shares at $1.266 + 15M warrants): +83% Aug 31, -23% Sep 1, +8.6% Sep 2, then +37.2% Sep 3. This was a speculative momentum/crypto-beta squeeze, not a company-specific fundamental catalyst.

Business bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW) is a San Antonio, Texas-based in-vitro diagnostics company developing noninvasive tests for early-stage lung cancer and other lung diseases using flow cytometry and proprietary AI. Its flagship CyPath® Lung test is marketed as a CLIA-regulated Laboratory Developed Test (LDT) by subsidiary Precision Pathology Laboratory Services (PPLS). The pipeline also spans asthma/COPD precision diagnostics and topically delivered skin-cancer therapeutics.

Today’s take On Sept 3, 2026, BIAF closed at $12.78, up 31.08% (+$3.03) from $9.75, capping a three-session re-rating ignited on Sept 1 by the announcement that CyPath® Lung would be advanced for surveillance of lung-cancer survivors after curative-intent treatment — expanding the test into a US market of 680,000+ survivors (vs ~230K new diagnoses/yr). The 9/3 session was a momentum continuation reinforced by same-day (Sept 3-dated) news that CEO Maria Zannes would present at the H.C. Wainwright 28th Annual Global Investment Conference (Sept 14–16) plus a new S-3/A registration filing that day. Roughly 19.2M shares changed hands — extraordinary turnover amplified by an ultra-thin float of only ~539–592K shares outstanding after the 1-for-15 reverse split effective Aug 24, 2026. Fundamental tailwind: Q2 CyPath test volume jumped 216% YoY with H1 testing revenue +159% to ~$835K (1,097 reports vs 390). No earnings/FDA/M&A event hit on 9/3 itself; the move is high-momentum thin-float continuation of clinical/business-development news.

Business Focus Universal Inc. (NASDAQ: FCUV) is a Nevada-incorporated developer of patented Internet of Things (IoT), 5G, and smart-farming hardware/software design technologies, headquartered in Monterey Park, California. It is pivoting toward a 'Deterministic AI' platform that automates SEC financial reporting (EDGARization, XBRL tagging) and business forms. The company is an extremely low-float microcap with roughly 648,000 shares outstanding and only ~$12.8M in market capitalization.

Today’s take FCUV closed up +29.88% to $19.69 on Sep 3, 2026 (open $15.36, high $19.95, low $15.31, volume ~390K), but no same-day company-specific news or regulatory filing was identified. The move was the continuation of a violent speculative melt-up: the stock rose +15.23% on Sep 1 to $11.35, +33.57% on Sep 2 to $15.16, and +29.88% on Sep 3, with RSI at 82.41 (overbought). The entire surge traces to the Deterministic AI retail narrative launched ~Jul 30-31, when FCUV spiked +517% to $11.60 on Jul 31 on ~103M shares traded (~$12.7B in volume) from a prior ~$2 level. The float is only ~547K shares (546,711 per stockanalysis), so ~390K daily volume equals massive float turnover. Fundamentals are weak: TTM revenue only ~$753K, net loss -$5.48M, cash $1.65M vs. $11.12M debt, book value $8.2M. A 1:4 reverse split occurred Jun 23, 2026, and shares outstanding grew ~127% QoQ (dilution). H.C. Wainwright conference showcase (Sep 14-16) was a known forward catalyst but not dated to Sep 3. This is best characterized as low-float, momentum/retail speculation absent a discrete news catalyst.

Business System1, Inc. (NYSE: SST) is a Los Angeles (Marina del Rey)-based marketing and customer-acquisition technology company operating a proprietary responsive acquisition marketing platform (RAMP). It reports two segments including owned-and-operated advertising and its partner network, and owns a portfolio of consumer brands such as MapQuest, Info.com, HowStuffWorks, Startpage and CouponFollow. The company went public via a SPAC (Trebia Acquisition Corp.) in early 2021 and acquired MapQuest from Verizon in 2019.

Today’s take On Sep 3, 2026, System1 (SST) surged +24.92% to close at $3.76 (intraday high $3.87) on 2.11M shares, capping a four-session viral momentum run from $1.89 on Aug 28. The catalyst was a story-driven retail rally: MapQuest, owned by System1, vaulted from #128 to #1 among free iPhone apps in the U.S. and #1 in Canada after publicly refusing to rename Lake Ontario to "Lake America" following President Trump's executive order. CBS/CNN reported downloads surged more than 6,000%, usage ran ~50x normal, and Sensor Tower estimated ~632K U.S. downloads (MapQuest itself cited ~1.5M US/Canada). The sequencing confirms no fundamental event on Sep 3 itself — Aug 31 +18.5% to $2.24 on 9.0M shares, Sep 1 +26.8% to $2.84, Sep 2 +5.99% to $3.01, then Sep 3 +24.9%. SST was still down ~40% YTD in 2026, and with Q2 revenue of ~$30.2M and a heavy debt load, the move was sentiment/volume-driven momentum rather than an earnings day.

Business Duluth Holdings Inc. (dba Duluth Trading Company), listed on NASDAQ, is a Wisconsin-based omnichannel retailer of workwear, hardware and casual lifestyle apparel sold direct-to-consumer and through retail stores. The company operates an aspirational lifestyle brand known for durable, functional clothing and gear.

Today’s take DLTH reported fiscal Q2 2026 (quarter ended Aug. 2) pre-market on Thursday, Sept. 3, 2026. Reported and adjusted EPS of $0.50 crushed consensus (roughly break-even, ~$0.00), while revenue of ~$121M edged above ~$119.9M expectations and declined 7.8% YoY from $131.7M on scaled-back promotions. The reported profit included $16.3M in tariff refunds booked against cost of goods sold (~$0.44 per share), accounting for most of the headline beat. Adjusted EBITDA more than doubled to $27.0M (22.3% margin) from $12.0M (9.1%) a year earlier; excluding tariff refunds it was $10.7M (8.8% of sales). Decisive for the move, management raised full-year 2026 adjusted EBITDA guidance by $10M to $38M-$42M (from $28M-$32M) while reaffirming net sales of $540M-$560M, reflecting genuine margin and turnaround progress (clearance inventory down 43% YoY). Investors rewarded both the beat and the guidance lift, sending shares +23.20% to close at $4.46 on Sept. 3. Some secondary headlines are dated Sept. 2, but the official press release, earnings date and conference call were all Sept. 3, and the entire +23.20% move/volume occurred on that session.

Business ZOOZ Strategy Ltd. is dual-listed on Nasdaq and the Tel Aviv Stock Exchange and headquartered in Lod, Israel. Formerly ZOOZ Power, a kinetic (flywheel) energy-storage company for EV fast-charging, it pivoted in 2025 to a Bitcoin treasury strategy, becoming the first Nasdaq/TASE dual-listed issuer to hold Bitcoin as its primary treasury reserve (roughly 1,000+ BTC).

Today’s take On Sep 3, 2026, ZOOZ shares closed at $7.97, up 22.62% (range $6.61-$8.27), a move that coincided with a broad crypto-market surge. Fed Governor Christopher Waller signaled openness to holding rates steady at the September FOMC, slashing September rate-hike odds and sparking a short squeeze that liquidated over $415M of short positions; Bitcoin broke back above $80,000, rising ~4.8-5% to ~$81,000 as bond yields retreated from 2026 highs. All crypto-exposed equities rallied in sympathy (Cannan ~+20%, Robinhood ~+15-16%, Strategy/MSTR ~+12-13%, Coinbase ~+9-11%). As a small-cap Bitcoin treasury proxy, ZOOZ amplified the sector move, gaining 22.6% on the session. ZOOZ trades as a high-beta leveraged play on its BTC holdings, so the macro-driven Bitcoin rebound was the direct catalyst for its outperformance on sharply elevated volume.

Business 17 Education & Technology Group Inc. (NASDAQ: YQ) is a Beijing-based AI-powered application service provider focused on personalized K-12 learning solutions. Its flagship consumer product is Yiqi Aixue, a membership-based adaptive AI learning service. One ADS represents 50 Class A ordinary shares.

Today’s take YQ surged +21.49% to $2.77 on 2026-09-03 (+$0.49) on a same-day corporate announcement: the board approved a new share repurchase program of up to US$10 million of ordinary shares (incl. ADSs) over a 12-month period from Sept. 3, 2026 to Sept. 2, 2027, funded from existing cash. Buyback news is typically well-received in small-cap names; RTTNews noted shares were up 11.9% to $2.5737 in pre-market and the prior regular session closed 9.62% higher. Buybacks were reinforced by verifiable insider accumulation: SEC filings show CEO & director Andy Chang Liu bought a total of 10,284 ADSs via holding entity Future Glory Technology Holdings Limited during Aug. 31-Sep. 2, 2026, including a 9,055-ADS open-market purchase on Sept. 2 at ~$2.19 (running to ~102,848 ADSs). The buyback plus fresh insider buying sent a coordinated management-confidence signal after the stock had drifted near/below $2.10-2.20. Context amplified the reaction: Q1 2026 revenue rose 359% YoY to RMB99.5M on its AI membership product Yiqi Aixue, with gross margin up to 61.9% and net loss narrowed to RMB19.4M, framing 2026 as an AI 'inflection point.' Short-squeeze mechanics were not a material driver as short interest is

Business Nutriband Inc. (NASDAQ: NTRB), headquartered in Orlando, Florida, is a pharmaceutical company developing transdermal products. Its lead candidate is AVERSA Fentanyl, an abuse-deterrent fentanyl patch for chronic pain management, alongside AVERSA buprenorphine and methylphenidate programs. It also markets sports-health and AI wellness products through subsidiaries.

Today’s take On Sep 3, 2026, NTRB closed at $5.63, up +19.79% (+$0.93), opening at $4.72 and reaching a high of $5.92 on volume of ~169,916 shares — roughly 5.8x the Aug-era average (~16K-29K). No dedicated company press release was published on Sep 3; the jump was a continuation of a speculative momentum run that began in mid-August, driven by Nutriband CEO Gareth Sheridan's scheduled CEO Spotlight appearance at the 2026 Georgia Life Sciences Summit (Aug 25-26), which triggered an extreme-volume spike of 253,136 shares on Aug 24 (+9.51%) and a 22.3% gain on Aug 21. The rally unfolded in a very low-float microcap (~12.16M shares outstanding, ~3.1M float, short interest ~3.2-4.9% of float per MarketWatch/stockanalysis). The Sep 3 surge also landed immediately ahead of the Sep 4 earnings date, likely adding pre-report speculative positioning. Recent price history shows shares recovering from multi-week lows; the day hit an intraday high of $5.92 before closing at $5.63.

Business American Bitcoin Corp. (NASDAQ: ABTC) is a Miami-based Bitcoin accumulation platform that operates industrial-scale ASIC mining and strategically builds a Bitcoin treasury reserve under a no-sale policy. Formerly American Data Centers, it completed a September 2025 stock-for-stock merger with Gryphon Digital Mining and is a majority-owned subsidiary of Hut 8 Corp., with Eric Trump as Co-Founder/CSO and Donald Trump Jr. as Senior Advisor.

Today’s take On Sept 3, 2026, ABTC closed at $9.34, up $1.47 (+18.68%), after opening $8.18 and trading up to a $9.47 high. The primary driver was a sector-wide Bitcoin-led rally: BTC surged ~4.8% to ~$81,100, breaking above the psychologically key $80,000 level for the first time in three months. Catalyst was Fed Governor Christopher Waller signaling at a Reuters NEXT event he would support a rate hold in September if inflation keeps improving; CME FedWatch September hike odds fell from 63.2% to 50.4%. Over $415M in BTC short positions were liquidated, adding a squeeze component. Sector confirmation was broad: Strategy +15-17.6%, Coinbase +10.1-10.6%, Robinhood +16.3-16.6%, Riot +11.4%, Mara +10-10.8%, Bit Digital +15.8-17.3%, Circle +15.8-16.5%, Canaan +23.4-27.8%. As a small-cap pure-play miner/treasury holding ~8,300 BTC (~$530M+ at session prices), ABTC functioned as a leveraged Bitcoin proxy, outperforming larger miners due to its concentrated balance-sheet BTC exposure. Prior session close was $7.87 on Sept 2. Treasury Department long-bond support and Trump's push for crypto legislation added tailwinds.

Business Intercont (Cayman) Limited (NCT) is a Singapore-headquartered global shipping enterprise engaged in time chartering and vessel management services, with plans to expand into seaborne pulping operations. The company trades on Nasdaq and previously effected a 25-for-1 reverse split in April 2026 to maintain listing compliance.

Today’s take NCT crashed 89.66% on September 3, 2026, plunging from $4.90 to $0.51 on massive volume of 23.7 million shares (vs. typical ~1 million). The collapse was driven by market anticipation of a dilutive convertible note financing agreement with Streeterville Capital, LLC (formally filed as Form 6-K on September 4), which involves issuing convertible notes and pre-delivery shares that will cause severe equity dilution. Having already executed a 25-for-1 reverse split in April 2026, this additional massive dilution signals acute financial distress, triggering panic selling and a complete loss of investor confidence.

Business Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE, HQ Novato, CA) is a clinical-stage biopharmaceutical company developing novel AAV-based gene therapies and antisense oligonucleotides (ASOs) for serious rare and ultra-rare genetic diseases. Its advanced programs include GENGLYCOS (DTX401) gene therapy for GSDIa (FDA-approved Aug 19, 2026) and UX111 gene therapy for Sanfilippo syndrome type A (PDUFA ~Sept 19, 2026), plus the unsuccessful apazunersen (GTX-102) ASO for Angelman syndrome.

Today’s take Ultragenyx shares collapsed ~44% to $14.85 on Sept 3, 2026 (intraday low $13.81, an all-time low) after the company announced after the Sept 2 close that its pivotal Phase 3 'Aspire' trial of apazunersen (GTX-102) in Angelman syndrome failed both its primary endpoint (change from baseline in Bayley-4 cognitive raw score) and key secondary endpoint (MDRI net response); notably, none of the five MDRI sub-domains separated from control, which the company itself and analysts called a clear signal failure rather than a design/measurement failure. This marked Ultragenyx's worst single-day percentage decline on record, capping a ~44% plunge from the prior ~$26.53 close. Management announced a strategic reassessment and 'significant expense reductions.' Sell-side reacted sharply: William Blair downgraded RARE to Market Perform from Outperform, Wells Fargo cut to Equal Weight with an $18 target, and TD Cowen lowered its price target. The setback is especially painful as apazunersen had been a key rare-neurology growth driver; it also poses a read-across for the similar Aurora UBE3A program. Context: the selloff followed the Aug 19 FDA approval of GENGLYCOS and precedes a Sept 19 PDUFA for U

Business Gix Internet Ltd (GIXI) is an Israeli technology company (formerly Algomizer Ltd) whose ordinary shares began trading on the Nasdaq Capital Market around September 1-2, 2026. Part of the Xylo Technologies group (~45.74% owner), it provides marketing-technology/software solutions and, through its 2025 acquisition of deliverz.ai, an AI-driven autonomous logistics platform for hospital environments. It employs ~11 people with only ~468,000 shares in free float.

Today’s take GIXI is a brand-new, ultra-thin Nasdaq micro-cap whose ordinary shares began US trading on/list ~Sept 1-2, 2026. On Sept 2 it rocketed ~+41% from its open of $8.49 to close at $12.00 (intraday high $15.50) on ~1.2M shares — pure debut momentum in a tiny float of only ~468,000 shares. On Sept 3, 2026 that parabolic run reversed violently: the stock opened at $7.65, traded a range of $5.70-$7.90, and closed down -43.75% at $6.75 on ~500K volume, making it the #2 US-listed decliner of the day. No company-specific news (no earnings, M&A or SEC event) was released Sept 3, so the drop reflects post-listing profit-taking/volatility reversal in a thin, retail-driven market cap of only ~$17.6M (2.08M shares out). The weak backdrop is notable: TTM revenue collapsed -72.7% to $8.55M, net loss ~$9.01M (EPS -$5.19), only ~$206K cash, negative working capital (-$3.6M), ROE -667%, and an Altman Z-score of -4.61 flagging bankruptcy risk — amplifying fragility behind the cascading decline.

Business Research Alliance Corporation III is a Cayman Islands-incorporated blank-check company (SPAC) sponsored by RA Capital Management, listed on the Nasdaq Capital Market under ticker RACC. It IPO'd in May 2026 at $10.00 and, on July 26, 2026, agreed to merge with rare-disease biotech Oak Hill Bio (new ticker OAKH) in a ~$175 million business combination advancing the antisense therapy rugonersen for Angelman syndrome.

Today’s take RACC collapsed 37.37% to $12.37 on Sep 3, 2026 (open $16.99, high $17.90, low $12.25) on ~833K shares, roughly 10-25x its ~33-78K 3-month average. There was no company-specific news that day; the move is the continuation of a violent unwind of a speculative low-float SPAC rally. After the July 26 Oak Hill Bio deal announcement, the stock ran from ~$10 trust value to a 52-week high of $33.50 on Aug 12 (from ~$11 in late July to ~$24-29 by mid-August), then decayed through late August ($21-22). On Sep 3 the shares mean-reverted sharply back toward the ~$10.00 trust/redemption value as the extraordinary general meeting (merger vote with redemption rights at trust value) approached, and with redemptions priced near $10, the speculative premium increasingly compressed. The -37% one-day collapse on 10x+ volume reflects profit-taking/momentum capitulation rather than fundamental news.

Business Aptevo Therapeutics Inc. (NASDAQ: APVO) is a Seattle, WA-based clinical-stage biotechnology company developing novel bispecific and trispecific immuno-oncology therapeutics via its proprietary ADAPTIR and ADAPTIR-FLEX platforms. Its lead candidate mipletamig targets CD123 in acute myeloid leukemia and is being evaluated in the RAINIER Phase 1b/2 trial.

Today’s take APVO plunged 34.23% to close at $1.71 (down $0.89 from the $2.60 prior close) on Sept 3, 2026, in a classic 'sell-the-news' reaction to the same-day release of positive mipletamig data from the RAINIER trial. Despite reporting a 93% clinical benefit rate and 79% CR/CRi in a small 14-patient cohort of TP53-mutated frontline AML — roughly double the published 41% ven/aza benchmark — the stock sold off from an open of $2.11, ranging $1.37-2.18 intraday. Sentiment was crushed by a heavy dilution overhang: an Aug 13, 2026 warrant exercise plus PIPE raised only ~$4.5M but set up a resale registration for up to 6.44M new shares versus just ~1.80M common outstanding (+7,302% YoY share growth), with a tiny ~$3.08M market cap. A thin $9.8M cash balance (2Q26), negative operating cash flow and a -94% 52-week slide from the $48.78 high into a $1.37 new low amplified the risk-off move. Roth Capital nonetheless called the AML data 'highly encouraging' the same day.

Business Connect Biopharma Holdings Limited (Nasdaq: CNTB) is a San Diego-headquartered clinical-stage biopharmaceutical company advancing rademikibart (CBP-201), a fully human anti-IL-4Ralpha monoclonal antibody, to treat acute exacerbations of asthma and COPD (Phase 2 Seabreeze STAT studies). It has granted Simcere an exclusive Greater-China license for rademikibart.

Today’s take CNTB collapsed -30.07% on 2026-09-03, closing at $1.93 after opening at $2.83 and spiking to an intraday high of $2.93 before selling off. The decline followed an aggressive momentum run into the widely-flagged early-September topline readout of the Phase 2 Seabreeze STAT Asthma study: shares rose +7.27% on Sep 1 and +16.95% on Sep 2 (close $2.76), lifting the 1-month gain to ~+40%. No negative Phase 2 data hit the tape that day, and the stock recovered to ~$2.05-2.13 in after-hours, so the -30% move reflected profit-taking/risk-unwinding by speculative holders ahead of the imminent binary clinical catalyst. It coincided with a broad Chinese small/micro-cap ADR rout (e.g., NCT -89.7%, LBGJ -25.6%, VIOT -23.6%), amplifying the reversal. Only the H.C. Wainwright conference presentation (Sept 3) was announced.

Business Polestar Automotive Holding UK PLC (NASDAQ: PSNY) is a premium pure-play electric performance car brand headquartered in Gothenburg, Sweden, majority-backed by China's Geely group (Geely Sweden and Volvo Cars). It designs, markets, and sells battery-electric vehicles including Polestar 2, 3, 4, and upcoming 5 across Europe (largest market), North America, Asia-Pacific, and importer markets.

Today’s take On Sept 3, 2026, Polestar reported H1/Q2 financial results pre-market and the stock crashed ~29.4% intraday — on track for its worst day on record — closing at $8.69, down 27.52%. Q2 EPS of -$2.19 missed consensus of -$1.81 by ~$0.38. Revenue fell 8.1% YoY to $727M (H1 revenue -4.4% to $1.36B) with retail volumes barely positive (+0.4% to 30,423 units H1) as EV competition intensified. Gross margin remained negative at -8.4% (H1). Management slashed FY2026 volume growth guidance from low-double-digit to 'low-to-mid single digits,' citing market pressure and the Polestar 2-to-Polestar 4 SUV portfolio transition. Compounding the selloff, the U.S. Commerce Department's BIS denied Polestar authorization to sell new vehicles in the U.S. from model year 2027 onward (China-linked Connected Vehicle Rule), forcing a ~$130M H1 restructuring charge; CEO Michael Lohscheller stated the company will not appeal. H1 net loss narrowed 29% to $842M, but stagnant sales, negative margins, guidance cut, and the US ban triggered panic selling.

Business Sono Group N.V. (Nasdaq: SSM), registered in the Netherlands, formerly built solar electric vehicles (Sono Motors) and now operates as a micro-cap digital-asset treasury company (~$7M market cap, ~15 employees). After signing a non-binding letter of intent with Sports One, it plans to become a permanent-capital vehicle holding minority stakes in NFL, NBA, MLB and NHL franchises.

Today’s take SSM plunged 27.08% on Sep 3, closing at $3.50 (low $3.28) after running up ~80% in two sessions. Following the Aug 30/31 non-binding LOI with Sports One (a vehicle to own minority pro-sports franchise stakes), the stock surged 77.43% on Sep 1 to $4.76 (34M shares, vs ~30K average) and +0.95% on Sep 2 to $4.80 (intraday high $5.40). On Sep 3 a morning release formally announced the offering of 283,500 shares (19.9% of outstanding, Sports One affiliates) to raise ~$556,945 net, with the 424B5 prospectus priced at $2.67/share. Simultaneously, 7 insider transactions were disclosed Sep 3: majority holder Bambino 255 V V sold 11,410 shares (~$41,969 at $3.67-3.75) on Sep 1, cutting ownership below the 10% threshold. The combination of fresh equity dilution, insider selling, heavy profit-taking on an unsupported speculative surge, and the still uncertain (due diligence, league/regulatory approval) non-binding deal drove the sharp reversal; volume collapsed to just 296,617 shares.

Business Liberty Defense Holdings, Ltd. (Nasdaq: DETX) develops and commercializes AI-based security detection technologies, chiefly HEXWAVE, a walk-through concealed-weapon/threat detection system for airports and other venues. The microcap went public in the U.S. on April 22, 2026 at $4.50/share (post 1-for-45 consolidation in March 2026), with Q2 2026 revenue collapsing ~90% YoY to ~$42K, substantial operating/net losses, heavy dilution via shares-for-debt settlements, and repeated SEC registration statements for securities offerings (most recently Aug 14, 2026).

Today’s take On the Sep 3, 2026 session Liberty Defense plunged ~27% to close at $2.60, printing a 52-week low of $2.501 intraday after trading as high as $3.91, on volume spiking to roughly 176-185K shares (about 30x the recent daily norm of ~4-7K). The move appears to be a distressed-microcap technical breakdown rather than a single dated company press release. The overhang centered on the Aug 14, 2026 securities-offering registration statement (the latest of several: Jun 1, Apr 30, etc.), the severely weak Q2 (revenue down ~90% YoY to ~$42K), the Aug 4 departure of President Bryan Cunningham, chronic dilution from shares-for-debt settlements/shares outstanding rising sharply, and general financial distress (deep negative Altman Z, low Piotroski F). With the stock already ~72% below its 52-week high and market cap near $19M, fund-flow/thin-liquidity selling drove a sharp mark-down through prior support into new lows.

Business IM Cannabis Corp. (Nasdaq: IMCC) is an international medical cannabis company operating a platform serving patients in Israel and, via Adjupharm GmbH, Germany. It imports and distributes cannabis to medical patients and operates medical cannabis retail pharmacies and online platforms in Israel. Following pending transactions announced August 17, 2026, it expects to retain Israeli operations while selling the German business.

Today’s take On Sept 3, 2026 IMCC plunged 26.67% to $2.20 (open $3.10, low $2.17) on elevated volume of ~127,575 shares, reacting to a dilutive US$225,000 convertible note financing announced after market close on Sept 2. The note carries a 10% original issuance discount, 8% interest (14% on default), is not repayable in cash, and converts solely into common shares at the lower of a fixed US$3.328 or 90% of the lowest 20-day VWAP (floor US$0.665692), with 77,855 share warrants — a floating conversion price that reset lower as shares fell, signaling severe dilution. This builds on distress: a 1-for-30 reverse stock split on Aug 27, 2026 to regain Nasdaq's $1 minimum bid compliance, going-concern warnings, and weak Q2 2026 revenue. Despite the tiny raise relative to a small market cap, the equity-linked terms and continued dilution pressure triggered the sharp one-day selloff. need_VolumeAnalysis=no.